GRP and prostate carcinoma: Siyuan, et al. [61] exploited knowledge of bombesin as a homolog of the gastrin-releasing peptide, which is capable of binding to the gastrin-releasing peptide receptor, GRPR [62,64], highly expressed in prostate cancer cells, and in other cancers [63].